Blue Light‐Induced, Dosed Protein Expression of Active BDNF in Human Cells Using the Optogenetic CRY2/CIB System
Biotechnology Journal · 2024
DOI: 10.1002/biot.202400384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Sina Christoffers und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Technical Chemistry, Leibniz University Hannover, Hannover, Germany. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Optogenetics, Cryptochromes, Light. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The use of optogenetic tools offers an excellent method for spatially and temporally regulated gene and protein expression in cell therapeutic approaches. This could be useful as a concomitant therapeutic measure, especially in small body compartments such as the inner ear, for example, during cochlea implantation, to enhance neuronal cell survival and function. Here, we used the blue light activatable CRY2/CIB system to induce transcription of brain‐derived neurotrophic factor (BDNF) in human cells. Transfection with three plasmids, encoding for the optogenetic system and the target, as well as illumination protocols were optimized with luciferase as a reporter to achieve the highest protein expression in human embryonic kidney cells 293. Illumination was performed either with a light‐emitting diode or with a scanning laser setup. The optimized protocols were applied for the production of BDNF. We could demonstrate a 64.7‐fold increase of BNDF expression upon light induction compared to the basal level. Light‐induced BDNF was biologically active and enhanced survival and neurite growth of spiral ganglion neurons. The optogenetic approach can be transferred to autologous cell systems, such as bone marrow‐derived mesenchymal stem cells, and thus represents the first optogenetic neurotrophic therapy for the inner ear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Technical Chemistry, Leibniz University Hannover, Hannover, Germany.
- Cluster of Excellence Hearing4all, Hannover, Germany.
- Institute of Quantum Optics, Leibniz University Hannover, Hannover, Germany.
- Department of Otorhinolaryngology, Hannover Medical School, Hannover, Germany.
- Institute of Microelectronic Systems, Leibniz University Hannover, Hannover, Germany.
ORCID-Profile: Sina Christoffers, Odett Kaiser, Cornelia Blume
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Christoffers, S., Wichert, N., Wiebe, E., Torres-Mapa, M. L., Goblet, M., Harre, J., Kaiser, O., Wahalla, M. N., Blume, H., Heisterkamp, A., Warnecke, A., & Blume, C. (2024). Blue Light‐Induced, Dosed Protein Expression of Active BDNF in Human Cells Using the Optogenetic CRY2/CIB System. Biotechnology Journal. https://doi.org/10.1002/biot.202400384
Vancouver
Christoffers S, Wichert N, Wiebe E, Torres-Mapa ML, Goblet M, Harre J, et al. Blue Light‐Induced, Dosed Protein Expression of Active BDNF in Human Cells Using the Optogenetic CRY2/CIB System. Biotechnology Journal. 2024. doi:10.1002/biot.202400384
BibTeX
@article{Christoffers2024,
author = {Christoffers, Sina and Wichert, Nina and Wiebe, Elena and Torres-Mapa, Maria Leilani and Goblet, Madeleine and Harre, Jennifer and Kaiser, Odett and Wahalla, Marc-Nils and Blume, Holger and Heisterkamp, Alexander and Warnecke, Athanasia and Blume, Cornelia},
title = {Blue Light‐Induced, Dosed Protein Expression of Active BDNF in Human Cells Using the Optogenetic CRY2/CIB System},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202400384}
}
EUVIMED